Back to Trades
Prener Anne
DirectorCIK 0001797917
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
Prener Anne, Director, has filed 4 SEC reports (2026), all concentrated in Keros Therapeutics, Inc. (KROS), totaling $173.6K in disclosed volume. Weighing $0 bought versus $11.8K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Nov 19 | KROS Keros Therapeutics, Inc. | Prener Anne | Director | Sell | $6.2K |
| Nov 16 | KROS Keros Therapeutics, Inc. | Prener Anne | Insider | Sell | $5.6K |
| Jul 6 | KROS Keros Therapeutics, Inc. | Prener Anne | Insider | Grant | $161.8K |
| Jul 6 | KROS Keros Therapeutics, Inc. | Prener Anne | Insider | Other | $0 |
4 filings